Baseline MRI lets AI predict Alzheimer's progression without cognitive testing

Millions of people are diagnosed with Alzheimer's disease each year, comprising 60% to 70% of dementia cases worldwide. While cognitive impairment and structural brain changes are indicative of Alzheimer's disease progression, the process to accurately predict who will develop Alzheimer's is time-consuming and requires a variety of techniques, including brain imaging, blood biomarkers, and neurocognitive testing by a neuropsychologist.